Description
Product Description:
Nindanix is adumbrated for the analysis of locally advanced, metastatic or locally alternate non-small corpuscle lung blight (NSCLC) adenocarcinoma blazon in aggregate with docetaxel for the analysis of developed patients afterwards the abortion of first-line chemotherapy.
Product Features:
Product Name: Nindanix
Generic Name: Nintedanib
Formulation: Capsule
Available Pack Size: 80 & 50 Capsule
Available Strength : 150 mg
Registrations: Available
Reviews
There are no reviews yet.